Company intelligence / Profile preview

BioDtech

Birmingham, Alabama, United States

Ownership: Private
Development stage: Other

Overview

BioDtech develops and markets reagents and systems for the detection, neutralization, and removal of endotoxin. Their products are used for quality control in injectable drugs, pharmaceutical water, medical devices, and environmental samples, as well as for diagnostic monitoring of gastrointestinal diseases and Gram-negative bacterial infections.

Industry: Protein Biomarker Diagnostics

Partnerships

Strategic partnerships with biopharmaceutical, pharmaceutical and medical device companiesLicense agreement with National University of Singapore

Beyond the preview

Go deeper on BioDtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioDtech.

Explore the full profile